<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arch Immunol Ther Exp (Warsz)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Arch. Immunol. Ther. Exp. (Warsz.)</journal-id>
      <journal-title-group>
        <journal-title>Archivum Immunologiae et Therapiae Experimentalis</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0004-069X</issn>
      <issn pub-type="epub">1661-4917</issn>
      <publisher>
        <publisher-name>Springer Basel</publisher-name>
        <publisher-loc>Basel</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25033772</article-id>
      <article-id pub-id-type="pmc">4164834</article-id>
      <article-id pub-id-type="publisher-id">299</article-id>
      <article-id pub-id-type="doi">10.1007/s00005-014-0299-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Two New Cases of <italic>KIR3DP1</italic>, <italic>KIR2DL4</italic>-Negative Genotypes, One of which is also Lacking <italic>KIR3DL2</italic></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Niepiek&#x142;o-Miniewska</surname>
            <given-names>Wanda</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#x17B;uk</surname>
            <given-names>Natalia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dubis</surname>
            <given-names>Joanna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kurpisz</surname>
            <given-names>Maciej</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Senitzer</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Havrylyuk</surname>
            <given-names>Anna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grendziak</surname>
            <given-names>Ryszard</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Witkiewicz</surname>
            <given-names>Wojciech</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chopyak</surname>
            <given-names>Valentyna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ku&#x15B;nierczyk</surname>
            <given-names>Piotr</given-names>
          </name>
          <address>
            <email>pkusnier@iitd.pan.wroc.pl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wroc&#x142;aw, Poland </aff>
        <aff id="Aff2"><label/>Research and Development Centre, Regional Specialised Hospital, Wroc&#x142;aw, Poland </aff>
        <aff id="Aff3"><label/>Department of Reproductive Biology and Stem Cells, Institute of Human Genetics, Polish Academy of Sciences, Pozna&#x144;, Poland </aff>
        <aff id="Aff4"><label/>City of Hope Comprehensive Cancer Center, Duarte, CA USA </aff>
        <aff id="Aff5"><label/>Department of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine </aff>
        <aff id="Aff6"><label/>Department of Vascular Surgery, Regional Specialised Hospital, Wroc&#x142;aw, Poland </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>7</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>18</day>
        <month>7</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2014</year>
      </pub-date>
      <volume>62</volume>
      <issue>5</issue>
      <fpage>423</fpage>
      <lpage>429</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>4</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2014</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>The killer immunoglobulin-like receptor (<italic>KIR</italic>) genes <italic>KIR2DL4</italic>, <italic>KIR3DL2,</italic> and <italic>KIR3DP1</italic> are present in virtually all humans. <italic>KIR2DL4</italic> encodes a receptor present on uterine and decidual natural killer (NK) cells and some peripheral blood NK cells. Its only known ligand is the human leukocyte antigen-G molecule expressed on extravillous trophoblasts, and on tissues in some diseases. KIR3DL2 binds HLA-A*03 and HLA-A*11 as well as HLA-B*27 dimers, and microbial CpG DNA. KIR3DP1 is a pseudogene. During our immunogenetic studies we found two individuals, one from Lower Silesia district in Poland, and another from Western Ukraine, who were reproducibly negative for <italic>KIR2DL4</italic> and <italic>KIR3DP1</italic> genes, using three different PCR systems. Both individuals displayed very similar genotypes, possessing only <italic>KIR3DL3</italic>, <italic>KIR2DL3</italic>, <italic>KIR2DP1</italic>, <italic>KIR2DS1</italic>, and probably a rare variant of <italic>KIR2DL1</italic>. The Pole had also <italic>KIR3DL2</italic>, which the Ukrainian was apparently lacking. The Lower Silesia has been populated after the Second World War by a remarkable percentage with displaced people from Western Ukraine, which might contribute to genetic similarity of the two individuals described here.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Killer cell immunoglobulin-like receptor</kwd>
        <kwd>Framework genes</kwd>
        <kwd>Deletion</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="intro">
      <title>Introduction</title>
      <p>Killer cell immunoglobulin-like receptors (KIRs) are present on natural killer (NK) cells and some subpopulations of T lymphocytes. They have either inhibitory (long cytoplasmic tail-receptors KIR2DL and KIR3DL possessing two or three extracellular immunoglobulin-like domains, respectively) or activating (short cytoplasmic tail-receptors KIR2DS or KIR3DS) properties upon binding a ligand. Genes for majority of KIRs are not present in all individuals but only in a fraction of them (haplotypic polymorphism). However, some, so called framework genes, namely <italic>KIR3DL3</italic>, <italic>KIR3DP1</italic>, <italic>KIR2DL4,</italic> and <italic>KIR3DL2</italic>, are present in virtually all genotypes (Jiang et al. <xref ref-type="bibr" rid="CR8">2012</xref>). Among these, <italic>KIR2DL4</italic> gene has special properties: it codes for structural features characteristic for both inhibitory and activating KIR; it is expressed in all NK cells whereas other KIRs are rather distributed clonally on some NK cells; and in contrast to other KIRs which function as cell surface receptors, it is localized, in resting NK cells, in endosomes where it may bind its ligand, a soluble HLA-G molecule (Rajagopalan and Long <xref ref-type="bibr" rid="CR18">2012</xref>), although this view has been recently challenged (Le Page et al. <xref ref-type="bibr" rid="CR11">2014</xref>). KIR2DL4 molecule appears as a cell surface receptor on uterine and decidual NK cells and some (mostly activated) peripheral blood NK cells (Goodridge et al. <xref ref-type="bibr" rid="CR6">2009</xref>; Hromadnikova et al. <xref ref-type="bibr" rid="CR7">2013</xref>; Yan et al. <xref ref-type="bibr" rid="CR27">2007</xref>). KIR3DL2 binds HLA-A*03 and HLA-A*11 as well as HLA-B*27 dimers, and also a microbial CpG DNA (Shaw and Kollnberger <xref ref-type="bibr" rid="CR19">2012</xref>; Sivori et al. <xref ref-type="bibr" rid="CR20">2010</xref>). KIR3DP1 is a pseudogene (Jiang et al. <xref ref-type="bibr" rid="CR8">2012</xref>). Here, we describe two cases of <italic>KIR2DL4</italic>-negative individuals detected in the Polish and Ukrainian populations. Both individuals present similar deletion of not only <italic>KIR2DL4</italic> but also neighboring <italic>KIR</italic> genes, including <italic>KIR3DP1</italic>. Interestingly, the Ukrainian individual was also lacking another framework gene, <italic>KIR3DL2</italic>.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec id="Sec3">
        <title>Study Subjects</title>
        <p>The study was approved by the Local Ethical Committee at the Research and Development Centre, Regional Specialised Hospital, Wroc&#x142;aw, the Bioethics Committee of the Medical University of Pozna&#x144;, and the Bioethics Committee of the Danylo Halytsky Lviv National Medical University.</p>
        <p><italic> No. 89</italic> a 69-year-old Polish male, 82&#xA0;kg body weight, 171&#xA0;cm high, body mass index (BMI) of 28.04, with arterial hypertension, morbus ischemicus cordis and aspirin idiosyncrazy but otherwise healthy and without genetic diseases in family.</p>
        <p><italic>No. 175</italic>&#xA0;<italic>K</italic> a 67-year-old Polish male, 90&#xA0;kg body weight, 177&#xA0;cm high, BMI of 28.73, with total cholesterol and glucose at upper border of the norm, atherosclerosis, polycystic kidney disease, varices, nosebleed, and osteoporosis.</p>
        <p><italic>No. 24</italic> a 22-year-old healthy male from western Ukraine, HIV-, HBV- and HCV-negative blood donor, recruited to a control group for our study on cryptorchidism (Kurpisz et al. <xref ref-type="bibr" rid="CR10">2011</xref>).</p>
        <p><italic>No. 58</italic> a 19-year-old healthy male from western Ukraine, HIV-, HBV- and HCV-negative blood donor, recruited to a control group for our study on cryptorchidism (Kurpisz et al. <xref ref-type="bibr" rid="CR10">2011</xref>).</p>
      </sec>
      <sec id="Sec4">
        <title>DNA Isolation</title>
        <p>Genomic DNA was isolated from venous blood using QIAamp DNA Blood Mini Kit Qiagen (Qiagen GmbH, Hilden, Germany), according to manufacturer&#x2019;s recommendations. DNA concentration was measured in NanoDrop 2000 UV&#x2013;Vis Spectrophotometer (Thermo Scientific, NanoDrop Products, Wilmington, Delaware, USA).</p>
      </sec>
      <sec id="Sec5">
        <title>KIR Typing</title>
        <p>Three PCR-sequence-specific primers (SSP) systems were used<list list-type="alpha-lower"><list-item><p>Olerup SSP KIR Genotyping kit (Olerup GmbH, Vienna, Austria), lot No. 07&#xA0;N including <italic>Taq</italic> polymerase. PCR-SSP procedure was performed according to manufacturer&#x2019;s instruction.</p></list-item><list-item><p>SSP as described by Vilches et al. (<xref ref-type="bibr" rid="CR25">2007</xref>) that enable to amplify short DNA fragments (96&#x2013;158&#xA0;bp), in our modification (Niepieklo-Miniewska et al. <xref ref-type="bibr" rid="CR12">2013</xref>)</p></list-item><list-item><p>Multiplex PCR-SSP (four PCR reactions containing primers for 3&#x2013;4 <italic>KIR</italic> genes each) as published earlier (Nowak et al. <xref ref-type="bibr" rid="CR14">2011</xref>; Sun et al. <xref ref-type="bibr" rid="CR21">2004</xref>).</p></list-item></list></p>
        <p>Our <italic>KIR</italic> typing has been validated three times per year by the International KIR Exchange program organized by the Immunogenetics Center of the University of California at Los Angeles.</p>
      </sec>
    </sec>
    <sec id="Sec7" sec-type="results">
      <title>Results</title>
      <p>Upon genomic <italic>KIR</italic> typing using commercial Olerup kit (see Materials and Methods) in disease association studies on Polish and Ukrainian patients and respective control groups, we noticed a lack of <italic>KIR2DL4</italic> gene in one Polish (No. 89&#xA0;K) and one Ukrainian (No. 24) control individual (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). All other samples from both control and patient groups were positive (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). The individual No. 24 apparently was lacking another framework gene, <italic>KIR3DL2</italic>, whereas another Ukrainian control individual, No. 58, possessed both genes (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). To confirm this result, we repeated <italic>KIR</italic> typing using Olerup kit once more, with the same result (data not shown, and see Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Furthermore, we checked the presence of <italic>KIR2DL4</italic> and <italic>KIR3DL2</italic> genes in these samples using primers published by Vilches et al. (<xref ref-type="bibr" rid="CR25">2007</xref>) (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). Finally, we typed these samples again with the use of multiplex PCR-SSP described previously (Sun et al. <xref ref-type="bibr" rid="CR21">2004</xref>) (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). Our individuals No. 89&#xA0;K and No. 24 were reproducibly <italic>KIR2DL4</italic>-negative in all these tests, in contrast to other individuals who were all positive (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref>, <xref rid="Fig3" ref-type="fig">3</xref>, and results not shown). They also lacked <italic>KIR3DP1</italic> which is present whenever <italic>KIR2DL4</italic> is present, with extremely rare exceptions (Jiang et al. <xref ref-type="bibr" rid="CR8">2012</xref>). They possessed <italic>KIR3DL3</italic>, <italic>2DL3</italic>, <italic>2DP1</italic>, and <italic>2DS1,</italic> and No. 89&#xA0;K had also <italic>KIR3DL2</italic>, absent from No. 24 genotype. Their genotypes contained <italic>KIR2DL3</italic> gene, characteristic for the centromeric segment of the KIR region, but another centromeric gene, <italic>KIR2DL1</italic>, gave inconsistent results: it was detected by multiplex test (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>; Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>) but neither by commercial test (Fig.&#xA0;<xref rid="Tab1" ref-type="table">1</xref>; Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) nor by PCR-SSP using primers described by Vilches et al. (<xref ref-type="bibr" rid="CR25">2007</xref>) (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Results of <italic>KIR</italic> typing using Olerup KIR Genotyping kit&#x2122;. Interpretation of all results is shown in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref> and described in the text. M: marker of the molecular mass; NC: negative control. Polish individual No. 89&#xA0;K; Ukrainian individual No. 24; Ukrainian individual No. 58</p></caption><graphic xlink:href="5_2014_299_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Summary of the results of testing individuals No. 89&#xA0;K, No. 24 and No. 58 with Olerup PCR-SSP kit shown in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref> and second testing with identical results</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Primer mix</th><th align="left">Size of specific PCR product (bp)</th><th align="left">Size of control band (bp)</th><th align="left">KIR gene</th><th align="left">No. 89&#xA0;K</th><th align="left">No. 24</th><th align="left">No. 58</th></tr></thead><tbody><tr><td align="left">1</td><td char="." align="char">145</td><td char="." align="char">800</td><td align="left">2DL1</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">2</td><td char="." align="char">145</td><td char="." align="char">1070</td><td align="left">2DL2</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">3</td><td char="." align="char">520</td><td char="." align="char">1070</td><td align="left">2DL3</td><td align="left">
<bold>+</bold>
</td><td align="left">
<bold>+</bold>
</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">4</td><td char="." align="char">200</td><td char="." align="char">1070</td><td align="left">
<bold>2DL4</bold>
</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">5</td><td char="." align="char">155</td><td char="." align="char">1070</td><td align="left">2DL5A, 2DL5B</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">6</td><td char="." align="char">1650</td><td char="." align="char">
<bold>430</bold>
</td><td align="left">2DL5A</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left">7</td><td char="." align="char">1650</td><td char="." align="char">
<bold>515</bold>
</td><td align="left">2DL5B</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">8</td><td char="." align="char">100</td><td char="." align="char">1070</td><td align="left">2DS1</td><td align="left">
<bold>+</bold>
</td><td align="left">
<bold>+</bold>
</td><td align="left">&#x2013;</td></tr><tr><td align="left">9</td><td char="." align="char">205</td><td char="." align="char">1070</td><td align="left">2DS2</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">10</td><td char="." align="char">160</td><td char="." align="char">1070</td><td align="left">2DS3</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">11</td><td char="." align="char">215</td><td char="." align="char">1070</td><td align="left">2DS4</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left">12</td><td char="." align="char">200</td><td char="." align="char">1070</td><td align="left">2DS4</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">13</td><td char="." align="char">110</td><td char="." align="char">1070</td><td align="left">2DS5</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left">14</td><td char="." align="char">130</td><td char="." align="char">1070</td><td align="left">3DL1</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">15</td><td char="." align="char">95</td><td char="." align="char">1070</td><td align="left">
<bold>3DL2</bold>
</td><td align="left">
<bold>+</bold>
</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">16</td><td char="." align="char">115</td><td char="." align="char">1070</td><td align="left">3DL3</td><td align="left">
<bold>+</bold>
</td><td align="left">
<bold>+</bold>
</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">17</td><td char="." align="char">130</td><td char="." align="char">1070</td><td align="left">3DS1</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left">18</td><td char="." align="char">165</td><td char="." align="char">1070</td><td align="left">2DP1</td><td align="left">
<bold>+</bold>
</td><td align="left">
<bold>+</bold>
</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">19</td><td char="." align="char">125</td><td char="." align="char">1070</td><td align="left">
<bold>3DP1</bold>
</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">20</td><td char="." align="char">235</td><td char="." align="char">1070</td><td align="left">3DP1</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">21</td><td char="." align="char">145</td><td char="." align="char">1070</td><td align="left">2DS1*001</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left">22</td><td char="." align="char">95</td><td char="." align="char">1070</td><td align="left">2DS1*002-008</td><td align="left">
<bold>+</bold>
</td><td align="left">
<bold>+</bold>
</td><td align="left">&#x2013;</td></tr><tr><td align="left">23</td><td char="." align="char">80</td><td char="." align="char">1070</td><td align="left">3DL1*00401-00403, 019, 021, 036, 037, 039, 056, 072</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">24</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>Negative control</bold>
</td><td align="left"/><td align="left"/><td align="left"/></tr></tbody></table><table-wrap-foot><p>Framework genes&#xA0;not detected in described individuals are show in bold</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Results of <italic>KIR</italic> typing using primers and PCR conditions described by Vilches et al. (<xref ref-type="bibr" rid="CR25">2007</xref>). <bold>a</bold>
<italic>KIR2DL4</italic> typing of samples No. 89&#xA0;K, No. 24 and two unrelated <italic>KIR2DL4</italic>-positive individuals. Both No. 89&#xA0;K (<italic>lane 1)</italic> and No. 24 (<italic>lane 2</italic>) were negative (only internal control gave a product), whereas both positive control samples (<italic>lanes 3</italic> and <italic>4</italic>) gave <italic>KIR2DL4</italic> amplicons. <bold>b</bold>
<italic>KIR3DL2</italic> typing of the same samples. Only sample No. 24 (<italic>lane 2</italic>) was negative for framework gene <italic>KIR3DL2</italic>, whereas both sample No. 89&#xA0;K (<italic>lane 1</italic>) and unrelated positive control samples (<italic>lanes 3</italic> and <italic>4</italic>) gave positive reactions. <bold>c</bold>
<italic>KIR2DL1</italic> typing of the same samples. Only control sample shown in <italic>lane 3</italic> was positive, whereas all other samples gave no product</p></caption><graphic xlink:href="5_2014_299_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Results of KIR typing using multiplex PCR-SSP kit (Sun et al. <xref ref-type="bibr" rid="CR21">2004</xref>). Samples No. 89&#xA0;K (<italic>lanes 2</italic>, <italic>5</italic>, <italic>8</italic> and <italic>11</italic>), No. 24 (<italic>lanes 3</italic>, <italic>6</italic>, <italic>9</italic> and <italic>12</italic>) and framework gene-positive control sample No. 175&#xA0;K (<italic>lanes 4</italic>, <italic>7</italic>, <italic>10</italic> and <italic>13</italic>) were tested for the presence of particular KIR gene groups as shown, together with results, in Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>. Please note the absence of KIR2DL4 (G1) in samples No. 89&#xA0;K and 24, and absence of KIR3DL2 (G3) in sample No. 24. KIR2DL1 (G1) gave clearly positive band in samples No. 89&#xA0;K and 24 in this test, in contrast to negative results of these samples with both Olerup (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>) and Vilches et al. (<xref ref-type="bibr" rid="CR25">2007</xref>)&#xA0;(Fig. <xref rid="Fig2" ref-type="fig">2</xref>) primers. Summary of these results is given in Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>
</p></caption><graphic xlink:href="5_2014_299_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Interpretation of results of multiplex PCR-SSP KIR typing shown in Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Multiplex group</th><th align="left">KIR gene</th><th align="left">Amplicon (bp)</th><th align="left">89&#xA0;K</th><th align="left">24</th><th align="left">175&#xA0;K</th></tr></thead><tbody><tr><td align="left" rowspan="4">1</td><td align="left">2DL1</td><td align="left">437</td><td align="left">+</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left">2DS3</td><td align="left">279</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">+</td></tr><tr><td align="left">
<bold>2DL4</bold>
</td><td align="left">
<bold>232</bold>
</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">2DL2</td><td char="." align="char">164</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">+</td></tr><tr><td align="left" rowspan="4">2</td><td align="left">3DL1</td><td align="left">565</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">+</td></tr><tr><td align="left">2DL3</td><td align="left">334</td><td align="left">+</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left">2DS2</td><td align="left">204</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">+</td></tr><tr><td align="left">3DS1</td><td char="." align="char">171</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left" rowspan="3">3</td><td align="left">2DS1</td><td align="left">231</td><td align="left">+</td><td align="left">+</td><td align="left">&#x2013;</td></tr><tr><td align="left">
<bold>3DL2</bold>
</td><td align="left">
<bold>142</bold>
</td><td align="left">
<bold>+</bold>
</td><td align="left">&#x2013;</td><td align="left">
<bold>+</bold>
</td></tr><tr><td align="left">2DL5</td><td char="." align="char">113</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">+</td></tr><tr><td align="left" rowspan="4">4</td><td align="left">2DS5</td><td align="left">194</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left">3DL3</td><td align="left">155</td><td align="left">+</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left">2DS4n</td><td align="left">130</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td></tr><tr><td align="left">2DS4d</td><td char="." align="char">108</td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="left">+</td></tr></tbody></table><table-wrap-foot><p>Framework genes&#xA0;not detected in described individuals are show in bold</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec8" sec-type="discussion">
      <title>Discussion</title>
      <p>We have detected two <italic>KIR3DP1</italic>, <italic>KIR2DL4</italic>-negative individuals, one of which was also negative for the third framework gene, <italic>KIR3DL2</italic>. Such genotypes are extremely rare in world populations (Djulejic et al. <xref ref-type="bibr" rid="CR2">2010</xref>; Ewerton et al. <xref ref-type="bibr" rid="CR3">2007</xref>; Gomez-Lozano et al. <xref ref-type="bibr" rid="CR4">2003</xref>; Gonzalez-Galarza et al. <xref ref-type="bibr" rid="CR5">2011</xref>; Karlsen et al. <xref ref-type="bibr" rid="CR9">2007</xref>; Norman et al. <xref ref-type="bibr" rid="CR13">2002</xref>; Nowak et al. <xref ref-type="bibr" rid="CR14">2011</xref>; Ozturk et al. <xref ref-type="bibr" rid="CR15">2012</xref>; Taniguchi and Kawabata <xref ref-type="bibr" rid="CR22">2009</xref>; Traherne et al. <xref ref-type="bibr" rid="CR23">2010</xref>; Velickovic et al. <xref ref-type="bibr" rid="CR24">2006</xref>), and even haplotypes contributing to them, most frequently in heterozygotic configuration, are very rare (Gonzalez-Galarza et al. <xref ref-type="bibr" rid="CR5">2011</xref>; Jiang et al. <xref ref-type="bibr" rid="CR8">2012</xref>; Pyo et al. <xref ref-type="bibr" rid="CR16">2010</xref>; <xref ref-type="bibr" rid="CR17">2013</xref>; Traherne et al. <xref ref-type="bibr" rid="CR23">2010</xref>). We found in the <ext-link ext-link-type="uri" xlink:href="http://www.allelefrequencies.net">www.allelefrequencies.net</ext-link> database (Gonzalez-Galarza et al. <xref ref-type="bibr" rid="CR5">2011</xref>) only ten <italic>KIR2DL4</italic>-negative genotypes in addition to two new ones described here (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a), three <italic>KIR3DL2</italic>-negative genotypes plus our Ukrainian (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>b), and six <italic>KIR3DP1</italic>-negative genotypes plus two described here (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>c) out of nearly 13,000 individuals tested worldwide (Gonzalez-Galarza et al. <xref ref-type="bibr" rid="CR5">2011</xref>). This speaks in favor of a strong positive selection for all three genes, including <italic>KIR3DP1</italic>. This pseudogene might be suspected to be preserved simply due to its close proximity to <italic>KIR2DL4</italic> which is likely strongly selected for. However, <italic>KIR3DP1</italic> is located on centromeric segment of KIR locus, whereas <italic>KIR2DL4</italic> is on telomeric segment (Jiang et al. <xref ref-type="bibr" rid="CR8">2012</xref>; Pyo et al. <xref ref-type="bibr" rid="CR17">2013</xref>) which seems to exclude the close localization as a reason for preservation of <italic>KIR3DP1</italic> together with <italic>KIR2DL4</italic>. Nevertheless, genotypes containing <italic>KIR2DL4,</italic> but not <italic>KIR3DP1,</italic> are extremely rare, as only few such genotypes from Cook, Samoa, Tokelau, and Tonga Islands as well as from Turkey have been described so far (Velickovic et al. <xref ref-type="bibr" rid="CR24">2006</xref>) (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>c), and opposite configuration, <italic>KIR3DP1</italic><sup>+</sup>, <italic>KIR2DL4</italic><sup>&#x2013;</sup>, was found in only single individuals from South Turkey, Brazil, and Bulgaria (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a). Homozygous <italic>KIR3DL2</italic> deletion is also very infrequent, as only three such cases exist in the database (Gonzalez-Galarza et al. <xref ref-type="bibr" rid="CR5">2011</xref>) and our Ukrainian No. 24 is the fourth one (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>b). Haplotypes with this deletion, but not in homozygous configuration, have been identified in some individuals by gene copy number detection (Pyo et al. <xref ref-type="bibr" rid="CR17">2013</xref>). The KIR3DL2 molecule plays an important role in both innate and adaptive immunity. It is expressed on NK cells, as well as on subpopulation(s) of T lymphocytes (Bowness et al. <xref ref-type="bibr" rid="CR1">2011</xref>; Wong-Baeza et al. <xref ref-type="bibr" rid="CR26">2013</xref>). It binds not only HLA-A*03 and HLA-A*11 heterotrimers as well as HLA-B*27 homodimers, but also microbial CpG DNA (Shaw and Kollnberger <xref ref-type="bibr" rid="CR19">2012</xref>; Sivori et al. <xref ref-type="bibr" rid="CR20">2010</xref>). It has the highest number of alleles, except for <italic>KIR3DL1/S1</italic>. This is suggestive of a strong selection for polymorphism (Shaw and Kollnberger <xref ref-type="bibr" rid="CR19">2012</xref>).<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>
<italic>KIR</italic> genotypes of published framework <italic>KIR</italic>-negative individuals. <bold>a</bold>
<italic>KIR2DL4</italic>-negative individuals. <italic>Gray shadowed cells</italic> gene present, <italic>white diagonally crossed cells</italic> gene absent, <italic>question mark</italic> gene presence dubious (inconsistent results), <italic>ND</italic> not done. <bold>b</bold> KIR genotypes of published <italic>KIR3DL2</italic>-negative individuals. Designations of cells as in Fig.&#xA0;4a. <bold>c</bold>
<italic>KIR</italic> genotypes of published <italic>KIR3DP1</italic>-negative individuals. Designations of cells as in Fig.&#xA0;4a. References: <italic>1</italic> Gomez-Lozano et al. <xref ref-type="bibr" rid="CR4">2003</xref>, <italic>2</italic> Nowak et al. <xref ref-type="bibr" rid="CR14">2011</xref>, <italic>3</italic> Gonzalez-Galarza et al. <xref ref-type="bibr" rid="CR5">2011</xref>, <italic>4</italic> Norman et al. <xref ref-type="bibr" rid="CR13">2002</xref>, <italic>5</italic> Taniguchi and Kawabata <xref ref-type="bibr" rid="CR22">2009</xref>, <italic>6</italic> Traherne et al. <xref ref-type="bibr" rid="CR23">2010</xref>, <italic>7</italic> Ewerton et al. <xref ref-type="bibr" rid="CR3">2007</xref>, <italic>8</italic> Karlsen et al. <xref ref-type="bibr" rid="CR9">2007</xref>
<italic>9</italic> Ozturk et al. <xref ref-type="bibr" rid="CR15">2012</xref>
<italic>10</italic> Djulejic et al. <xref ref-type="bibr" rid="CR2">2010</xref>, <italic>11</italic> Velickovic et al. <xref ref-type="bibr" rid="CR24">2006</xref>
</p></caption><graphic xlink:href="5_2014_299_Fig4_HTML" id="MO4"/></fig></p>
      <p>In some very rare American haplotypes, most of the <italic>KIR3DL</italic>2 gene (intron 3 to beyond exon 9) was deleted, giving a typing pattern identical to our No. 24. Such a haplotype has also been detected in an American of Ukrainian descent, in addition in homozygous configuration (Traherne et al. <xref ref-type="bibr" rid="CR23">2010</xref>).</p>
      <p>Interestingly, Lower Silesia was populated in remarkable fraction, after the Second World War, by people resettled from Western Ukraine. Therefore, not only No. 24 but also No. 89&#xA0;K genotype may be derived from there, whence similarity between these genotypes and with haplotypes described in the USA and mentioned above. It has been established by sequencing that all American <italic>KIR3DL2</italic> deletion haplotypes contained exons 1&#x2013;3 from <italic>KIR3DL2*007</italic> allele, suggesting a recent common origin. It would be desirable then to check whether our genotypes No. 89&#xA0;K and No. 24 bear the same allele that may be derived from the same recombination event.</p>
      <p>We had a problem with establishing whether <italic>KIR2DL1</italic> gene is present in our genotypes No. 89&#xA0;K and No. 24. The reagents from both Olerup and Vilches et al. (<xref ref-type="bibr" rid="CR25">2007</xref>) PCR-SSP gave reproducibly negative results, whereas in the multiplex assay both individuals were clearly positive (Figs.&#xA0;<xref rid="Tab1" ref-type="table">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref>, <xref rid="Fig3" ref-type="fig">3</xref>; Tables&#xA0;<xref rid="Tab1" ref-type="table">1</xref>, <xref rid="Tab2" ref-type="table">2</xref>). It is likely that both our individuals possess genotypes similar to the haplotypes described earlier in Northern American Caucasian population (Pyo et al. <xref ref-type="bibr" rid="CR17">2013</xref>; Traherne et al. <xref ref-type="bibr" rid="CR23">2010</xref>) which contained a <italic>KIR2DL1/KIR2DS1</italic> hybrid resulting from recombination event which deleted all <italic>KIR</italic> genes located between these two genes. This may explain why some PCRs detected <italic>KIR2DL1</italic> in our samples, but other did not.</p>
      <p>In conclusion, we found in our Slavic populations (Polish and Ukrainian), two individuals lacking several framework <italic>KIR</italic> genes, <italic>KIR3DP1,</italic> and <italic>KIR2DL4</italic>, and apparently also <italic>KIR2DL1</italic>. One of them was also negative for <italic>KIR3DL2</italic>. Both these individuals were relatively healthy in spite of very limited <italic>KIR</italic> gene repertoire. However, such genotypes are extremely rare in world populations. Therefore, studies on much larger populations would be required to determine the effect(s) of these deletions on the health of such individuals.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The research described in this paper was supported by two projects: WROVASC&#x2013;&#x2013;&#x201C;Integrated Centre of Cardiovascular Medicine&#x201D; co-founded by the European Fund of Regional Development and national budget (the Innovative Economy Operational Program 2007&#x2013;2013 1-1), and a grant from the Polish Ministry of Science and Higher Education No. NN407193439.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bowness</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ridley</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Th17 cells expressing KIR3DL2&#xA0;+&#xA0;and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis</article-title>
          <source>J Immunol</source>
          <year>2011</year>
          <volume>186</volume>
          <fpage>2672</fpage>
          <lpage>2680</lpage>
          <pub-id pub-id-type="doi">10.4049/jimmunol.1002653</pub-id>
          <pub-id pub-id-type="pmid">21248258</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Djulejic</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Petlichkovski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Trajkov</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distribution of killer cell immunoglobulinlike receptors in the Macedonian population</article-title>
          <source>Hum Immunol</source>
          <year>2010</year>
          <volume>71</volume>
          <fpage>281</fpage>
          <lpage>288</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humimm.2009.12.001</pub-id>
          <pub-id pub-id-type="pmid">20004695</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ewerton</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Leite Mde</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Magalhaes</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Amazonian Amerindians exhibit high variability of KIR profiles</article-title>
          <source>Immunogenetics</source>
          <year>2007</year>
          <volume>59</volume>
          <fpage>625</fpage>
          <lpage>630</lpage>
          <pub-id pub-id-type="doi">10.1007/s00251-007-0229-3</pub-id>
          <pub-id pub-id-type="pmid">17551723</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomez-Lozano</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>de Pablo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Puente</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction</article-title>
          <source>Eur J Immunol</source>
          <year>2003</year>
          <volume>33</volume>
          <fpage>639</fpage>
          <lpage>644</lpage>
          <pub-id pub-id-type="doi">10.1002/eji.200323741</pub-id>
          <pub-id pub-id-type="pmid">12616484</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzalez-Galarza</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Christmas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Middleton</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations</article-title>
          <source>Nucleic Acids Res</source>
          <year>2011</year>
          <volume>39</volume>
          <issue>Database issue</issue>
          <fpage>D913</fpage>
          <lpage>D919</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkq1128</pub-id>
          <pub-id pub-id-type="pmid">21062830</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goodridge</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Lathbury</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>John</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The genotype of the NK receptor, KIR2DL4, influences IFNgamma secretion by decidual natural killer cells</article-title>
          <source>Mol Hum Reprod</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>489</fpage>
          <lpage>497</lpage>
          <pub-id pub-id-type="doi">10.1093/molehr/gap039</pub-id>
          <pub-id pub-id-type="pmid">19509110</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hromadnikova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Pirkova</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sedlackova</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors</article-title>
          <source>Mediators Inflamm</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>405295</fpage>
          <pub-id pub-id-type="pmid">23476104</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jayaraman</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors</article-title>
          <source>Genome Res</source>
          <year>2012</year>
          <volume>22</volume>
          <fpage>1845</fpage>
          <lpage>1854</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.137976.112</pub-id>
          <pub-id pub-id-type="pmid">22948769</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karlsen</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Boberg</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Olsson</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis</article-title>
          <source>J Hepatol</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>899</fpage>
          <lpage>906</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jhep.2007.01.032</pub-id>
          <pub-id pub-id-type="pmid">17383044</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kurpisz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakonechnyy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Niepieklo-Miniewska</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Weak association of anti-sperm antibodies and strong association of familial cryptorchidism/infertility with HLA-DRB1 polymorphisms in prepubertal Ukrainian boys</article-title>
          <source>Reprod Biol Endocrinol</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>129</fpage>
          <pub-id pub-id-type="doi">10.1186/1477-7827-9-129</pub-id>
          <pub-id pub-id-type="pmid">21955839</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le Page</surname>
              <given-names>MEL</given-names>
            </name>
            <name>
              <surname>Goodridge</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>John</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Killer Ig-like receptor 2DL4 does not mediatte NK cell IFG-&#x3B3; responses to soluble HLA-G preparations</article-title>
          <source>J Immunol</source>
          <year>2014</year>
          <volume>192</volume>
          <fpage>732</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="doi">10.4049/jimmunol.1301748</pub-id>
          <pub-id pub-id-type="pmid">24337374</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niepieklo-Miniewska</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Majorczyk</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Matusiak</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Protective effect of the KIR2DS1 gene in atopic dermatitis</article-title>
          <source>Gene</source>
          <year>2013</year>
          <volume>527</volume>
          <fpage>594</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="doi">10.1016/j.gene.2013.06.015</pub-id>
          <pub-id pub-id-type="pmid">23831511</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Norman</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Carrington</surname>
              <given-names>CV</given-names>
            </name>
            <name>
              <surname>Byng</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations</article-title>
          <source>Genes Immun</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>86</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.gene.6363836</pub-id>
          <pub-id pub-id-type="pmid">11960306</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nowak</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Majorczyk</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ploski</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lack of KIR2DL4 gene in a fertile Caucasian woman</article-title>
          <source>Tissue Antigens</source>
          <year>2011</year>
          <volume>78</volume>
          <fpage>115</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1399-0039.2011.01711.x</pub-id>
          <pub-id pub-id-type="pmid">21623736</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozturk</surname>
              <given-names>OG</given-names>
            </name>
            <name>
              <surname>Polat</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Atik</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Diversity of killer cell immunoglobulin-like receptor genes in Southern Turkey</article-title>
          <source>Mol Biol Rep</source>
          <year>2012</year>
          <volume>39</volume>
          <fpage>1989</fpage>
          <lpage>1995</lpage>
          <pub-id pub-id-type="doi">10.1007/s11033-011-0945-5</pub-id>
          <pub-id pub-id-type="pmid">21655956</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pyo</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Guethlein</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Vu</surname>
              <given-names>Q</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus</article-title>
          <source>PLoS ONE</source>
          <year>2010</year>
          <volume>5</volume>
          <fpage>e15115</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0015115</pub-id>
          <pub-id pub-id-type="pmid">21206914</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pyo</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Vu</surname>
              <given-names>Q</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recombinant structures expand and contract inter and intragenic diversification at the KIR locus</article-title>
          <source>BMC Genom</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>89</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-14-89</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajagopalan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>EO</given-names>
            </name>
          </person-group>
          <article-title>KIR2DL4 (CD158d): an activation receptor for HLA-G</article-title>
          <source>Front Immunol</source>
          <year>2012</year>
          <volume>3</volume>
          <fpage>258</fpage>
          <pub-id pub-id-type="doi">10.3389/fimmu.2012.00258</pub-id>
          <pub-id pub-id-type="pmid">22934097</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shaw</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kollnberger</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease</article-title>
          <source>Front Immunol</source>
          <year>2012</year>
          <volume>3</volume>
          <fpage>339</fpage>
          <pub-id pub-id-type="doi">10.3389/fimmu.2012.00339</pub-id>
          <pub-id pub-id-type="pmid">23162554</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sivori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Falco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Carlomagno</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2</article-title>
          <source>Blood</source>
          <year>2010</year>
          <volume>116</volume>
          <fpage>1637</fpage>
          <lpage>1647</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2009-12-256586</pub-id>
          <pub-id pub-id-type="pmid">20147700</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Gaidulis</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>MM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotyping</article-title>
          <source>Tissue Antigens</source>
          <year>2004</year>
          <volume>64</volume>
          <fpage>462</fpage>
          <lpage>468</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1399-0039.2004.00303.x</pub-id>
          <pub-id pub-id-type="pmid">15361123</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taniguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kawabata</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection</article-title>
          <source>Immunogenetics</source>
          <year>2009</year>
          <volume>61</volume>
          <fpage>717</fpage>
          <lpage>730</lpage>
          <pub-id pub-id-type="doi">10.1007/s00251-009-0401-z</pub-id>
          <pub-id pub-id-type="pmid">19859704</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traherne</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex</article-title>
          <source>Hum Mol Genet</source>
          <year>2010</year>
          <volume>19</volume>
          <fpage>737</fpage>
          <lpage>751</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddp538</pub-id>
          <pub-id pub-id-type="pmid">19959527</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Velickovic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Velickovic</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Dunckley</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations</article-title>
          <source>Immunogenetics</source>
          <year>2006</year>
          <volume>58</volume>
          <fpage>523</fpage>
          <lpage>532</lpage>
          <pub-id pub-id-type="doi">10.1007/s00251-006-0124-3</pub-id>
          <pub-id pub-id-type="pmid">16733717</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vilches</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Castano</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gomez-Lozano</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments</article-title>
          <source>Tissue Antigens</source>
          <year>2007</year>
          <volume>70</volume>
          <fpage>415</fpage>
          <lpage>422</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1399-0039.2007.00923.x</pub-id>
          <pub-id pub-id-type="pmid">17854430</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong-Baeza</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ridley</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis</article-title>
          <source>J Immunol</source>
          <year>2013</year>
          <volume>190</volume>
          <fpage>3216</fpage>
          <lpage>3224</lpage>
          <pub-id pub-id-type="doi">10.4049/jimmunol.1202926</pub-id>
          <pub-id pub-id-type="pmid">23440420</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yan</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>BG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Possible roles of KIR2DL4 expression on uNK cells in human pregnancy</article-title>
          <source>Am J Reprod Immunol</source>
          <year>2007</year>
          <volume>57</volume>
          <fpage>233</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0897.2007.00469.x</pub-id>
          <pub-id pub-id-type="pmid">17362384</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
